EBS
NYSE Emergent BioSolutions Inc.$6.60 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.60, $0.28 below the day’s high of $6.88
- YTD change
- -46.60%
- vs 20-day SMA
- +1.91%
- vs 200-day SMA
- -23.96%
Price ranges
Price & Performance
-1.45 (-18.01%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 95.2% away from all-time highs of $137.61
- EBS is down 47% since the beginning of the year
- EBS is down 25% over the past 12 months
- EBS is up 8% over the past 1 month
- 20% of all EBS investors are betting against EBS
- Number of investors short EBS has gone down 1% versus last month
EBS reads not so good: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is -25.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -2.37%
- vs 8-day SMA
- -2.44%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
